(c) 2024 PillSync.com

24 HR tramadol hydrochloride Extended Release Oral Tablet

1 INDICATIONS AND USAGE Tramadol hydrochloride extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Limitations of Use: • Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations [see Warnings and Precautions (5.1) ] , reserve tramadol hydrochloride extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. • Tramadol hydrochloride extended-release tablets are not indicated as an as-needed (prn) analgesic. Tramadol hydrochloride extended-release tablets are an opioid agonist indicated for the management of pain severe enough to require daily around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. ( 1 ) Limitations of Use • Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve tramadol hydrochloride extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. ( 1 ) • Tramadol hydrochloride extended-release tablets are not indicated as an as-needed (prn) analgesic. ( 1 )

Mylan Pharmaceuticals Inc.


5 years ago OVAL WHITE MT2 24 HR tramadol hydrochloride Extended Release Oral Tablet

OVAL WHITE MT2

5 years ago OVAL WHITE MT2 24 HR tramadol hydrochloride Extended Release Oral Tablet

MT2 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING Tramadol Hydrochloride Extended-Release Tablets, USP are available containing 100 mg, 200 mg or 300 mg of tramadol hydrochloride, USP. The 100 mg tablets are white to off-white, coated, round, unscored tablets imprinted with M over T1 in black ink on one side of the tablet and plain on the other side. They are available as follows: NDC 0378-4152-93 bottles of 30 tablets The 200 mg tablets are white to off-white, coated, oval, unscored tablets imprinted with MT2 in black ink on one side of the tablet and plain on the other side. They are available as follows: NDC 0378-4153-93 bottles of 30 tablets The 300 mg tablets are white to off-white, coated, capsule shaped, unscored tablets imprinted with MT3 in black ink on one side of the tablet and plain on the other side. They are available as follows: NDC 0378-4154-93 bottles of 30 tablets Store at 20º to 25ºC (68º to 77ºF). [See USP Controlled Room Temperature.] Store tramadol hydrochloride extended-release tablets securely and dispose of properly [see Patient Counseling Information (17) ] . Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. PHARMACIST: Dispense a Medication Guide with each prescription.


More pills like OVAL MT2

Related Pills

metoprolol succinate 50 mg

Mylan Institutional Inc.

metoprolol succinate 50 mg

Mylan Institutional Inc.

metoprolol succinate 50 mg

Mylan Institutional Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site